NAD Nasal Spray vs Injections: Format, Price and Evidence

A prescription NAD nasal spray from Arc-1 is listed at $149.99, half the $299.99 price of the same service's NAD+ injections, and a research-grade NAD+ liquid spray from Real Peptides costs $120.00. Needle-free formats have grown fast because many people dislike injections, but the trade-off is evidence: Arc-1 itself lists limited bioavailability data for the nasal route as a drawback.

I compare the spray and injection formats below on price, access and what is actually known. None of these NAD+ products is FDA-approved.

Spray and Injection Formats at a Glance

Three NAD+ products in this comparison differ by format, access and status. Here they are side by side, using the vendors' published details.

The two Arc-1 products both include a physician consultation and pharmacy compounding, ship direct to the door and come with 30-day returns. The Real Peptides spray ships from US stock with a third-party COA and free US shipping on orders over $250.

What We Know About Nasal Absorption of NAD+

Very little published data shows how much NAD+ reaches the bloodstream through the nose, and that is the central weakness of the nasal spray format. Arc-1 lists "bioavailability data limited for nasal route" among the product's cons, which is an unusually frank admission for a seller.

Human evidence for NAD+ by any route is limited, and most strong data concern cell and animal models. For sprays the gap is wider, because even the basic question of absorption is not settled. A spray that feels convenient is not evidence that it delivers anything comparable to an injection.

Absorption also depends on things a product page cannot control: the spray device, how much runs down the throat, and the condition of the nasal lining. Studies would need to measure blood levels after a nasal dose to settle the question, and that work is not in the published record we draw on.

When a seller claims its NAD nasal spray is "as effective as injections", ask for the study. We have not seen controlled human data supporting that comparison.

Prescription Spray vs Research Spray

The Arc-1 spray is a prescription medical product; the Real Peptides spray is research material that is not for human consumption. They look similar on a product page, and the price gap is only $29.99, which is exactly why buyers confuse them.

A practical check for any NAD nasal spray listing: look for who stands behind it. A prescription spray names a telehealth platform, a physician step and a compounding pharmacy. A research spray names a COA and a "not for human consumption" label. If a listing shows neither, skip it.

With Arc-1, a physician reviews your online intake before the pharmacy compounds the spray, and the prescriber decides whether it suits you. With Real Peptides, nobody reviews anything. The 1000mg content works out to $0.12 per mg, which is useful for a lab budget, but the label says research use only and the vendor provides no use guidance. In August 2026 FDA made clear that it looks past "research use only" labels to the whole website, so a research vendor offering usage advice would be inviting a warning letter.

Choosing Between a Spray and an Injection

For a person considering NAD+, the choice between a spray and an injection is one to make with a prescriber, not from a price list. A few factors are worth raising in that conversation:

• Needle tolerance: the main practical reason people ask about sprays.
• Evidence: nasal bioavailability data is limited, so the spray carries more uncertainty.
• Ongoing cost: the Arc-1 spray is sold on a monthly subscription model, while the injection program is listed at $299.99.
• Side effects: most clinic reports of flushing and nausea come from IV use; spray-specific data is thin.

Our pages on NAD injection side effects and NAD injection costs add detail on the last two points.

Where Sprays Fit in the Wider NAD+ Market

Sprays are the newest format in a market that also includes clinic IV drips, prescription injections and oral precursor supplements such as NMN and NR. Each format answers a different practical wish: no needles, no clinic visits, or no prescription. None of them has strong controlled human data behind its benefit claims.

If you are looking at the oral route instead, the NAD vs NMN vs NR comparison explains how precursors differ from NAD+ itself. Whatever format you consider, a doctor is the right person to decide whether NAD+ belongs in your plans.